A Randomized Phase III Study Of Gemcitabine In Combination With Radiation Therapy Versus Gemcitabine Alone In Patients With Localized, Unresectable Pancreatic Cancer.
Phase of Trial: Phase III
Latest Information Update: 12 Feb 2013
At a glance
- Drugs Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 03 Oct 2011 Results published in the Journal of Clinical Oncology.
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2008 Results reported at ASCO 2008 (1113271)